Healthcare provider profile · identity verified

Ramsey Lee Gardner, MD

Internal Medicine · NELLIS AFB, NV · NPI 1225535255

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	629	139
Gabapentin	Gabapentin	459	92
Eliquis	Apixaban	415	62
Furosemide	Furosemide	308	66
Levothyroxine Sodium	Levothyroxine Sodium	296	50
Amlodipine Besylate	Amlodipine Besylate	283	71
Pantoprazole Sodium	Pantoprazole Sodium	275	54
Tamsulosin Hcl	Tamsulosin Hcl	204	45
Jardiance	Empagliflozin	191	24
Losartan Potassium	Losartan Potassium	186	36
Trazodone Hcl	Trazodone Hcl	180	42
Metformin Hcl	Metformin Hcl	171	33
Potassium Chloride	Potassium Chloride	171	31
Metoprolol Tartrate	Metoprolol Tartrate	166	40
Escitalopram Oxalate	Escitalopram Oxalate	154	24
Mirtazapine	Mirtazapine	120	32
Levetiracetam	Levetiracetam	115	17
Carvedilol	Carvedilol	114	27
Lisinopril	Lisinopril	111	31
Divalproex Sodium	Divalproex Sodium	110	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	103	26
Famotidine	Famotidine	96	26
Duloxetine Hcl	Duloxetine Hcl	93	16
Clopidogrel	Clopidogrel Bisulfate	92	28
Donepezil Hcl	Donepezil Hcl	88	12
Memantine Hcl	Memantine Hcl	87	13
Hydralazine Hcl	Hydralazine Hcl	82	29
Quetiapine Fumarate	Quetiapine Fumarate	82	16
Sertraline Hcl	Sertraline Hcl	80	21
Spironolactone	Spironolactone	80	20
Xarelto	Rivaroxaban	80	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	77	37
Brilinta	Ticagrelor	75	suppressed
Lactulose	Lactulose	74	15
Montelukast Sodium	Montelukast Sodium	74	16
Buspirone Hcl	Buspirone Hcl	70	13
Olanzapine	Olanzapine	70	12
Baclofen	Baclofen	69	19
Metoprolol Succinate	Metoprolol Succinate	64	25
Diclofenac Sodium	Diclofenac Sodium	60	16
Simvastatin	Simvastatin	58	suppressed
Trulicity	Dulaglutide	58	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	56	23
Humalog Kwikpen U-100	Insulin Lispro	55	18
Insulin Lispro Kwikpen U-100	Insulin Lispro	55	20
Finasteride	Finasteride	53	16
Omeprazole	Omeprazole	53	20
Sodium Chloride	0.9 % Sodium Chloride	50	11
Fluticasone Propionate	Fluticasone Propionate	48	17
Fluoxetine Hcl	Fluoxetine Hcl	47	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	44	11
Clonidine Hcl	Clonidine Hcl	43	suppressed
Allopurinol	Allopurinol	41	suppressed
Arformoterol Tartrate	Arformoterol Tartrate	41	suppressed
Amiodarone Hcl	Amiodarone Hcl	40	13
Sevelamer Carbonate	Sevelamer Carbonate	40	12
Lidocaine	Lidocaine	39	suppressed
Chlorthalidone	Chlorthalidone	36	suppressed
Risperidone	Risperidone	35	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	33	suppressed
Calcium Acetate	Calcium Acetate	31	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	31	suppressed
Alendronate Sodium	Alendronate Sodium	30	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Xifaxan	Rifaximin	30	suppressed
Budesonide	Budesonide	29	12
Ondansetron Hcl	Ondansetron Hcl	29	24
Carbidopa-Levodopa	Carbidopa/Levodopa	28	suppressed
Latanoprost	Latanoprost	28	suppressed
Albuterol Sulfate	Albuterol Sulfate	27	17
Midodrine Hcl	Midodrine Hcl	26	suppressed
Warfarin Sodium	Warfarin Sodium	26	suppressed
Atenolol	Atenolol	25	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Lamotrigine	Lamotrigine	25	suppressed
Ibuprofen	Ibuprofen	24	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Aripiprazole	Aripiprazole	23	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	23	suppressed
Glipizide	Glipizide	23	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Primidone	Primidone	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	14
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Lithium Carbonate	Lithium Carbonate	22	suppressed
Prednisone	Prednisone	22	11
Vancomycin Hcl	Vancomycin Hcl	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Sucralfate	Sucralfate	20	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Lubiprostone	Lubiprostone	19	suppressed
Cephalexin	Cephalexin	18	15
Divalproex Sodium Er	Divalproex Sodium	18	suppressed
Otezla	Apremilast	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	17	suppressed
Febuxostat	Febuxostat	17	suppressed
Humulin R	Insulin Regular, Human	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	14
Valproic Acid	Valproic Acid (As Sodium Salt)	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Icosapent Ethyl	Icosapent Ethyl	16	suppressed
Incruse Ellipta	Umeclidinium Bromide	16	suppressed
Risperidone Odt	Risperidone	16	suppressed
Spiriva Respimat	Tiotropium Bromide	16	suppressed
Topiramate	Topiramate	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Bumetanide	Bumetanide	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Nitroglycerin	Nitroglycerin	15	11
Nystop	Nystatin	15	11
Scopolamine	Scopolamine	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Valsartan	Valsartan	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Caplyta	Lumateperone Tosylate	14	suppressed
Dulera	Mometasone/Formoterol	14	suppressed
Fenofibrate	Fenofibrate,micronized	14	suppressed
Kapspargo Sprinkle	Metoprolol Succinate	14	suppressed
Levofloxacin	Levofloxacin	14	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	13
Prochlorperazine Maleate	Prochlorperazine Maleate	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	14	suppressed
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Azithromycin	Azithromycin	12	suppressed
Glatiramer Acetate	Glatiramer Acetate	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Insulin Degludec Pen (U-100)	Insulin Degludec	12	suppressed
Letrozole	Letrozole	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Dapagliflozin	Dapagliflozin Propanediol	11	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	11	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Insulin Aspart Flexpen	Insulin Aspart	11	suppressed
Isoniazid	Isoniazid	11	suppressed
Mesalamine	Mesalamine	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Sevelamer Hcl	Sevelamer Hcl	11	suppressed
Tramadol Hcl	Tramadol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error